The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 57,396 | 13,633,220 | SH | SOLE | 13,633,220 | 0 | 0 | ||
| ACORDA THERAPEUTICS INC | COM | 00484M106 | 10,286 | 489,828 | SH | SOLE | 489,828 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 36,190 | 2,184,047 | SH | SOLE | 2,184,047 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 10,478 | 828,283 | SH | SOLE | 828,283 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 151,480 | 5,409,990 | SH | SOLE | 5,409,990 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 9,073 | 532,426 | SH | SOLE | 532,426 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 123,565 | 1,625,211 | SH | SOLE | 1,625,211 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 8,786 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 29,314 | 3,489,795 | SH | SOLE | 3,489,795 | 0 | 0 | ||
| CALITHERA BIOSCIENCES INC | COM | 13089P101 | 8,374 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 8,257 | 2,428,571 | SH | SOLE | 2,428,571 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 4,056 | 354,200 | SH | SOLE | 354,200 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC | COM | 29664W105 | 24,883 | 704,701 | SH | SOLE | 704,701 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 9,010 | 1,820,138 | SH | SOLE | 1,820,138 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 8,818 | 1,025,291 | SH | SOLE | 1,025,291 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,616 | 591,070 | SH | SOLE | 591,070 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 12,579 | 298,935 | SH | SOLE | 298,935 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 3,907 | 79,899 | SH | SOLE | 79,899 | 0 | 0 | ||
| MYOVANT SCIENCES LTD | COM | G637AM102 | 27,570 | 2,348,422 | SH | SOLE | 2,348,422 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,150 | 636,248 | SH | SOLE | 636,248 | 0 | 0 | ||
| RA PHARMACEUTICALS INC | COM | 74933V108 | 28,780 | 1,351,808 | SH | SOLE | 1,351,808 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 8,155 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 194,938 | 7,088,651 | SH | SOLE | 7,088,651 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 26,596 | 2,451,237 | SH | SOLE | 2,451,237 | 0 | 0 | ||